Aemetis, Inc. Reports First Quarter 2021 Financial Results
Aemetis, a renewable fuels company, reported Q1 2021 revenues of $42.8 million, an 8% increase from $39.5 million in Q1 2020, driven by rising ethanol demand and prices. Ethanol prices rose from $1.40 to over $2.90 per gallon amidst economic recovery and stricter EPA regulations. Despite these gains, the company faced a net loss of $18.1 million compared to $12.1 million in Q1 2020, attributed to increased operating and administrative expenses, alongside weaker crush margins. Cash reserves improved to $15.8 million due to stock sales.
- 8% increase in Q1 2021 revenues to $42.8 million.
- Ethanol prices rose significantly, indicating strong market demand.
- Established $16.8 million in energy efficiency grants for plant upgrades.
- Approval of projects enhancing growth potential, including the Carbon Zero renewable jet/diesel project.
- Net loss increased to $18.1 million from $12.1 million year-over-year.
- Operating loss worsened to $9.0 million from $4.5 million in Q1 2020.
- Selling, general and administrative expenses rose to $5.4 million.
CUPERTINO, CA / ACCESSWIRE / May 12, 2021 / Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, today announced its financial results for the three months ended March 31, 2021.
"On track with our Five Year Plan, revenues from ethanol sales in Q1 2021 increased
"We are pleased with the milestones accomplished during the first quarter of 2021, including our Carbon Zero renewable jet/diesel project receiving an exclusive license to use the patented technology that extracts low-cost, low carbon sugar from waste wood for use in biofuels production, significant progress shown by the recent issuance of 19 key permits for construction of the jet/diesel plant, and the awarding of energy efficiency grants that now provide a total of
Today, Aemetis will host an earnings review call at 11:00 a.m. Pacific Time (PT).
Live Participant Dial In (Toll Free): +1-844-407-9500
Live Participant Dial In (International): +1-862-298-0850
Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/41240
For details on the call, please visit http://www.aemetis.com/investors/conference-calls/.
Financial Results for the Three Months Ended March 31, 2021
Revenues during the first quarter of 2021 increased to
Gross loss for the first quarter of 2021 was
Selling, general and administrative expenses increased to
Operating loss was
Interest expense, excluding accretion of Series A preferred units in the Aemetis Biogas LLC subsidiary, increased to
Net loss increased to
Cash at the end of the first quarter of 2021 was
About Aemetis
Headquartered in Cupertino, California, Aemetis is a renewable natural gas, renewable fuel and bioproducts company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. Founded in 2006, Aemetis has completed Phase 1 and is expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas (RNG). Aemetis owns and operates a 65 million gallon per year ethanol production facility in California's Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis also owns and operates a 50 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is developing the Carbon Zero plant in Riverbank, California to convert cellulosic hydrogen from waste orchard wood and renewable electricity from solar and hydroelectric sources into renewable jet and diesel fuel. Aemetis holds a portfolio of patents and related technology licenses for the production of renewable fuels and bioproducts. For additional information about Aemetis, please visit www.aemetis.com.
NON-GAAP FINANCIAL INFORMATION
We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest expense, income tax expense, intangible and other amortization expense, accretion expense, depreciation expense and share-based compensation expense.
Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes. EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison.
Safe Harbor Statement
This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, statements relating to our five-year growth plan, future growth in revenue, expansion into new markets, our ability to commercialize and scale the licensed patented technology, the ability to obtain sufficiently low Carbon Intensity scores to achieve below zero carbon intensity transportation fuels, the development of the Aemetis Biogas Dairy project, the development of the Aemetis Carbon Zero plant at the Riverbank site, the upgrades to the Aemetis Keyes ethanol plant, the development of the Aemetis Carbon Capture projects, and the ability to access the funding required to execute on project construction and operations.. Words or phrases such as "anticipates," "may," "will," "should," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "showing signs," "targets," "will likely result," "will continue" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2020, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.
(Tables follow)
AEMETIS, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(unaudited, in thousands except per share data)
Three months ended | ||||||||
March 31, 2021 | March 31, 2020 | |||||||
Revenues | $ | 42,807 | $ | 39,480 | ||||
Cost of goods sold | 46,415 | 39,913 | ||||||
Gross loss | (3,608 | ) | (433 | ) | ||||
Research and development expenses | 23 | 117 | ||||||
Selling, general and administrative expenses | 5,382 | 3,936 | ||||||
Operating loss | (9,013 | ) | (4,486 | ) | ||||
Other expense/(income) | ||||||||
Interest rate expense | 5,965 | 5,586 | ||||||
Debt related fees and amortization expense | 1,215 | 1,290 | ||||||
Accretion of Series A preferred units | 1,943 | 960 | ||||||
Other income | (31 | ) | (63 | ) | ||||
Loss before income taxes | (18,105 | ) | (12,259 | ) | ||||
Income tax expense/(benefit) | 7 | (207 | ) | |||||
Net loss | $ | (18,112 | ) | $ | (12,052 | ) | ||
Net loss per common share | ||||||||
Basic | $ | (0.69 | ) | $ | (0.58 | ) | ||
Diluted | $ | (0.69 | ) | $ | (0.58 | ) | ||
Weighted average shares outstanding | ||||||||
Basic | 26,289 | 20,651 | ||||||
Diluted | 26,289 | 20,651 | ||||||
AEMETIS, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(unaudited, in thousands)
March 31, 2021 | December 31, 2020 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 15,787 | $ | 592 | ||||
Accounts receivable | 1,755 | 1,821 | ||||||
Inventories | 4,210 | 3,969 | ||||||
Prepaid and other current assets | 2,464 | 2,301 | ||||||
Total current assets | 24,216 | 8,683 | ||||||
Property, plant and equipment, net | 113,090 | 109,880 | ||||||
Other assets | 6,427 | 6,576 | ||||||
Total assets | $ | 143,733 | $ | 125,139 | ||||
Liabilities and stockholders' deficit | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 17,574 | $ | 20,739 | ||||
Current portion of long-term debt | 11,848 | 44,974 | ||||||
Short term borrowings | 13,559 | 14,541 | ||||||
Mandatorily redeemable Series B stock | 3,277 | 3,252 | ||||||
Accrued property taxes | 6,085 | 5,674 | ||||||
Accrued contingent litigation fees | 6,200 | 6,200 | ||||||
Other liabilities | 7,823 | 6,855 | ||||||
Total current liabilities | 66,366 | 102,235 | ||||||
Total long term liabilities | 215,734 | 207,648 | ||||||
Total stockholders' deficit: | ||||||||
Series B convertible preferred stock | 1 | 1 | ||||||
Common stock | 30 | 23 | ||||||
Additional paid-in capital | 157,933 | 93,426 | ||||||
Accumulated deficit | (292,192 | ) | (274,080 | ) | ||||
Accumulated other comprehensive loss | (4,139 | ) | (4,114 | ) | ||||
Total stockholders' deficit | (138,367 | ) | (184,744 | ) | ||||
Total liabilities and stockholders' deficit | $ | 143,733 | $ | 125,139 | ||||
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)
(unaudited, in thousands)
Three months ended | ||||||||
March 31, | ||||||||
2021 | 2020 | |||||||
Net loss | $ | (18,112 | ) | $ | (12,052 | ) | ||
Adjustments: | ||||||||
Interest expense | 7,180 | 6,876 | ||||||
Depreciation expense | 1,386 | 1,090 | ||||||
Accretion of Series A preferred units | 1,943 | 960 | ||||||
Share-based compensation | 835 | 310 | ||||||
Intangibles and other amortization expense | 12 | 12 | ||||||
Income tax expense/(benefit) | 7 | (207 | ) | |||||
Total adjustments | 11,363 | 9,041 | ||||||
Adjusted EBITDA | $ | (6,749 | ) | $ | (3,011 | ) | ||
PRODUCTION AND PRICE PERFORMANCE
(unaudited)
Three months ended | ||||||||
March 31, | ||||||||
2021 | 2020 | |||||||
Ethanol | ||||||||
Gallons sold (in millions) | 15.6 | 15.7 | ||||||
Average sales price/gallon | ||||||||
Percent of nameplate capacity | ||||||||
WDG | ||||||||
Tons sold (in thousands) | 104 | 107 | ||||||
Average sales price/ton | ||||||||
Delivered Cost of Corn | ||||||||
Bushels ground (in millions) | 5.5 | 5.7 | ||||||
Average delivered cost / bushel | ||||||||
Biodiesel | ||||||||
Metric tons sold (in thousands) | 0.3 | 3.6 | ||||||
Average Sales Price/Metric ton | ||||||||
Percent of nameplate capacity | ||||||||
Refined glycerin | ||||||||
Metric tons sold (in thousands) | 0.1 | 0.1 | ||||||
Average Sales Price/Metric ton | ||||||||
SOURCE: Aemetis, Inc.
View source version on accesswire.com:
https://www.accesswire.com/646696/Aemetis-Inc-Reports-First-Quarter-2021-Financial-Results
FAQ
What were Aemetis's Q1 2021 revenues?
How did Aemetis's net loss change in Q1 2021?
What factors contributed to the revenue increase for Aemetis?